2Flo Ventures

Vivacelle Bio Featured in The Lancet Journal

January 28, 2024

Vivacelle Bio has been featured in the esteemed Lancet Journal. In the link below, it details the results and significance of their positive Phase 2A data for their treatment of hypovolemia due to septic shock.

Learn more here: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00009-9/fulltext

Location & Contact

222 W Merchandise Mart Plaza | Suite 1230 | Chicago, IL 60654


2Flo Ventures